Ocular Inflammation Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: O6B3C5E35C08EN
Market Monitor Global

Abstracts

Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.

This report contains market size and forecasts of Ocular Inflammation Treatment in Global, including the following market information:

Global Ocular Inflammation Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ocular Inflammation Treatment market was valued at 20810 million in 2021 and is projected to reach US$ 29840 million by 2028, at a CAGR of 5.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunosuppressant Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ocular Inflammation Treatment include Allergan, Cipla, Pfizer, Novartis, Valeant Pharmaceuticals International, Alimera Sciences, Akorn, Abbvie and Eyegate Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ocular Inflammation Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ocular Inflammation Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ocular Inflammation Treatment Market Segment Percentages, by Type, 2021 (%)

• Immunosuppressant
• Monoclonal Antibodies
• Corticosteroids
• Cycloplegic Agents
• Antibiotics
• Analgesics
• Antivirals
• Antifungal

Global Ocular Inflammation Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ocular Inflammation Treatment Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Drug Stores

Global Ocular Inflammation Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ocular Inflammation Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ocular Inflammation Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ocular Inflammation Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Cipla
• Pfizer
• Novartis
• Valeant Pharmaceuticals International
• Alimera Sciences
• Akorn
• Abbvie
• Eyegate Pharmaceuticals
• pSivida

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ocular Inflammation Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ocular Inflammation Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OCULAR INFLAMMATION TREATMENT OVERALL MARKET SIZE

2.1 Global Ocular Inflammation Treatment Market Size: 2021 VS 2028
2.2 Global Ocular Inflammation Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ocular Inflammation Treatment Players in Global Market
3.2 Top Global Ocular Inflammation Treatment Companies Ranked by Revenue
3.3 Global Ocular Inflammation Treatment Revenue by Companies
3.4 Top 3 and Top 5 Ocular Inflammation Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ocular Inflammation Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ocular Inflammation Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Ocular Inflammation Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ocular Inflammation Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ocular Inflammation Treatment Market Size Markets, 2021 & 2028
  4.1.2 Immunosuppressant
  4.1.3 Monoclonal Antibodies
  4.1.4 Corticosteroids
  4.1.5 Cycloplegic Agents
  4.1.6 Antibiotics
  4.1.7 Analgesics
  4.1.8 Antivirals
  4.1.9 Antifungal
4.2 By Type - Global Ocular Inflammation Treatment Revenue & Forecasts
  4.2.1 By Type - Global Ocular Inflammation Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Ocular Inflammation Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Ocular Inflammation Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ocular Inflammation Treatment Market Size, 2021 & 2028
  5.1.2 Retail Pharmacies
  5.1.3 Hospital Pharmacies
  5.1.4 Online Pharmacies
  5.1.5 Drug Stores
5.2 By Application - Global Ocular Inflammation Treatment Revenue & Forecasts
  5.2.1 By Application - Global Ocular Inflammation Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Ocular Inflammation Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Ocular Inflammation Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ocular Inflammation Treatment Market Size, 2021 & 2028
6.2 By Region - Global Ocular Inflammation Treatment Revenue & Forecasts
  6.2.1 By Region - Global Ocular Inflammation Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Ocular Inflammation Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Ocular Inflammation Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ocular Inflammation Treatment Revenue, 2017-2028
  6.3.2 US Ocular Inflammation Treatment Market Size, 2017-2028
  6.3.3 Canada Ocular Inflammation Treatment Market Size, 2017-2028
  6.3.4 Mexico Ocular Inflammation Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ocular Inflammation Treatment Revenue, 2017-2028
  6.4.2 Germany Ocular Inflammation Treatment Market Size, 2017-2028
  6.4.3 France Ocular Inflammation Treatment Market Size, 2017-2028
  6.4.4 U.K. Ocular Inflammation Treatment Market Size, 2017-2028
  6.4.5 Italy Ocular Inflammation Treatment Market Size, 2017-2028
  6.4.6 Russia Ocular Inflammation Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Ocular Inflammation Treatment Market Size, 2017-2028
  6.4.8 Benelux Ocular Inflammation Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ocular Inflammation Treatment Revenue, 2017-2028
  6.5.2 China Ocular Inflammation Treatment Market Size, 2017-2028
  6.5.3 Japan Ocular Inflammation Treatment Market Size, 2017-2028
  6.5.4 South Korea Ocular Inflammation Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Ocular Inflammation Treatment Market Size, 2017-2028
  6.5.6 India Ocular Inflammation Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ocular Inflammation Treatment Revenue, 2017-2028
  6.6.2 Brazil Ocular Inflammation Treatment Market Size, 2017-2028
  6.6.3 Argentina Ocular Inflammation Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ocular Inflammation Treatment Revenue, 2017-2028
  6.7.2 Turkey Ocular Inflammation Treatment Market Size, 2017-2028
  6.7.3 Israel Ocular Inflammation Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Ocular Inflammation Treatment Market Size, 2017-2028
  6.7.5 UAE Ocular Inflammation Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Ocular Inflammation Treatment Major Product Offerings
  7.1.4 Allergan Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.1.5 Allergan Key News
7.2 Cipla
  7.2.1 Cipla Corporate Summary
  7.2.2 Cipla Business Overview
  7.2.3 Cipla Ocular Inflammation Treatment Major Product Offerings
  7.2.4 Cipla Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.2.5 Cipla Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Ocular Inflammation Treatment Major Product Offerings
  7.3.4 Pfizer Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Ocular Inflammation Treatment Major Product Offerings
  7.4.4 Novartis Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Valeant Pharmaceuticals International
  7.5.1 Valeant Pharmaceuticals International Corporate Summary
  7.5.2 Valeant Pharmaceuticals International Business Overview
  7.5.3 Valeant Pharmaceuticals International Ocular Inflammation Treatment Major Product Offerings
  7.5.4 Valeant Pharmaceuticals International Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.5.5 Valeant Pharmaceuticals International Key News
7.6 Alimera Sciences
  7.6.1 Alimera Sciences Corporate Summary
  7.6.2 Alimera Sciences Business Overview
  7.6.3 Alimera Sciences Ocular Inflammation Treatment Major Product Offerings
  7.6.4 Alimera Sciences Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.6.5 Alimera Sciences Key News
7.7 Akorn
  7.7.1 Akorn Corporate Summary
  7.7.2 Akorn Business Overview
  7.7.3 Akorn Ocular Inflammation Treatment Major Product Offerings
  7.7.4 Akorn Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.7.5 Akorn Key News
7.8 Abbvie
  7.8.1 Abbvie Corporate Summary
  7.8.2 Abbvie Business Overview
  7.8.3 Abbvie Ocular Inflammation Treatment Major Product Offerings
  7.8.4 Abbvie Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.8.5 Abbvie Key News
7.9 Eyegate Pharmaceuticals
  7.9.1 Eyegate Pharmaceuticals Corporate Summary
  7.9.2 Eyegate Pharmaceuticals Business Overview
  7.9.3 Eyegate Pharmaceuticals Ocular Inflammation Treatment Major Product Offerings
  7.9.4 Eyegate Pharmaceuticals Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.9.5 Eyegate Pharmaceuticals Key News
7.10 pSivida
  7.10.1 pSivida Corporate Summary
  7.10.2 pSivida Business Overview
  7.10.3 pSivida Ocular Inflammation Treatment Major Product Offerings
  7.10.4 pSivida Ocular Inflammation Treatment Revenue in Global Market (2017-2022)
  7.10.5 pSivida Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ocular Inflammation Treatment Market Opportunities & Trends in Global Market
Table 2. Ocular Inflammation Treatment Market Drivers in Global Market
Table 3. Ocular Inflammation Treatment Market Restraints in Global Market
Table 4. Key Players of Ocular Inflammation Treatment in Global Market
Table 5. Top Ocular Inflammation Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ocular Inflammation Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ocular Inflammation Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ocular Inflammation Treatment Product Type
Table 9. List of Global Tier 1 Ocular Inflammation Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ocular Inflammation Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ocular Inflammation Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ocular Inflammation Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ocular Inflammation Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ocular Inflammation Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ocular Inflammation Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ocular Inflammation Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ocular Inflammation Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ocular Inflammation Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ocular Inflammation Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ocular Inflammation Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ocular Inflammation Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ocular Inflammation Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ocular Inflammation Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ocular Inflammation Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Ocular Inflammation Treatment Product Offerings
Table 32. Allergan Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Cipla Corporate Summary
Table 34. Cipla Ocular Inflammation Treatment Product Offerings
Table 35. Cipla Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Ocular Inflammation Treatment Product Offerings
Table 38. Pfizer Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Ocular Inflammation Treatment Product Offerings
Table 41. Novartis Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Valeant Pharmaceuticals International Corporate Summary
Table 43. Valeant Pharmaceuticals International Ocular Inflammation Treatment Product Offerings
Table 44. Valeant Pharmaceuticals International Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Alimera Sciences Corporate Summary
Table 46. Alimera Sciences Ocular Inflammation Treatment Product Offerings
Table 47. Alimera Sciences Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Akorn Corporate Summary
Table 49. Akorn Ocular Inflammation Treatment Product Offerings
Table 50. Akorn Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Abbvie Corporate Summary
Table 52. Abbvie Ocular Inflammation Treatment Product Offerings
Table 53. Abbvie Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Eyegate Pharmaceuticals Corporate Summary
Table 55. Eyegate Pharmaceuticals Ocular Inflammation Treatment Product Offerings
Table 56. Eyegate Pharmaceuticals Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)
Table 57. pSivida Corporate Summary
Table 58. pSivida Ocular Inflammation Treatment Product Offerings
Table 59. pSivida Ocular Inflammation Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ocular Inflammation Treatment Segment by Type in 2021
Figure 2. Ocular Inflammation Treatment Segment by Application in 2021
Figure 3. Global Ocular Inflammation Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ocular Inflammation Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ocular Inflammation Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ocular Inflammation Treatment Revenue in 2021
Figure 8. By Type - Global Ocular Inflammation Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ocular Inflammation Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ocular Inflammation Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ocular Inflammation Treatment Revenue Market Share, 2017-2028
Figure 12. US Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ocular Inflammation Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ocular Inflammation Treatment Revenue Market Share, 2017-2028
Figure 24. China Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ocular Inflammation Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ocular Inflammation Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ocular Inflammation Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cipla Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Valeant Pharmaceuticals International Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Alimera Sciences Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Akorn Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Abbvie Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Eyegate Pharmaceuticals Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. pSivida Ocular Inflammation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)